Delivery Order HHSN261201600022I-HHSN26100004
Award Date 5/1/18
Potential Completion Date 8/31/21
Potential Value $28K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Pittsburgh, PA 15213, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a $59,335 delivery order to the University of Pittsburgh on September 16, 2019, for analytical support and pharmacokinetic sample analysis under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients IDIQ. The order supports preclinical pharmacology studies evaluating agents in development for cancer patients. Work is performed in Pittsburgh, PA, under a firm fixed price structure. The period of performance runs from September 16, 2019,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $208,940.00 firm-fixed-price delivery order contract to the University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh. The contract is for pharmacokinetic studies with selected anticancer compounds in NSG mice, with a period of performance from September 13, 2019 to September 12, 2024. This contract is under a larger...
- This is a $110,445.12 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's cancer research efforts. The contract has no set-aside designation, indicating it was competed openly. The University...
- The National Cancer Institute issued a $35,252.94 delivery order to Sri International on February 24, 2020, under the NIH Analysis of Anti-Cancer Chemicals 2017-2022 IDIQ for release analysis of anti-cancer drug bulk lots. The order covers analytical chemistry work including appearance assessment, polymorphic form determination, infrared spectroscopy, high-performance liquid chromatography assay and impurity analysis, moisture determination, residual solvent testing, refractive index...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of Pittsburgh, a state-related research university in Pennsylvania. The $122,754.24 firm fixed-price contract was awarded on May 4, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract (IDC). The contract is for the provision of tissue samples and data from various types of cancer to support the...
- <p>The National Cancer Institute awarded a purchase order to the University of Pittsburgh for $19,634.16 on September 30, 2013, with final completion on December 31, 2014. The order supports developing capacity to design and implement strategies to deliver precision behavior medicine in cancer prevention and control. Work is performed in Pittsburgh, Pennsylvania. The contract carries firm fixed pricing with no set-aside applied.</p>
- This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $67,882,919.00, is a cost-plus-fixed-fee delivery order for the PDX PANELS FROM COMMON TUMORS project. The work is to be performed at the Fort Detrick facility in Maryland and has a completion date of September 25, 2027. The contract does not have a set-aside...
- This is a $1,112,184.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Research Institute at Nationwide Children's Hospital, a non-profit research organization. The contract is for nucleic acid extractions and biospecimen core resource services to support studies conducted by NCI's Division of Cancer Epidemiology and Genetics (DCEG). The award has an ultimate completion date of August 31,...